Mergers and Acquisitions
bianca33
JohnsonJohnsonpowerpoint.pptxJohnson & Johnson
Ronesha Gohagon
Davenport University
J&J is a global firm created in 1886 aimed at developing pharmaceuticals, medical devices, and client packaged items. The company ranks no. 36 on the Fortune 500 list of America’s biggest companies by total returns. It is a valuable firm and is among the two firms in the U.S. having a prime credit rating of AAA. The corporation has operations in 60 nations and its goods are sold in more than 175 nations making international sales of $82.6 billion in 2020. J&J success in its Covid-19 vaccine plan can make the company stock valuation to increase significantly. J&J is worth $428.7 billion in market cap making it the largest pharmaceutical firm in the world.
Description of Johnson & Johnson (J&J) Company
J&J is the biggest pharmaceutical firm in the world and is ranked no.36 among the Fortune 500 companies in America.
2
Pfizer Inc. is an American global biotechnology and pharmaceutical firm established in 1849. The firm manufactures medicines and vaccines for diverse reasons such as cardiology and oncology. It has different products or drugs generating more than US $1 billion in annual returns. The company generated global sales of $41.9 billion in 2020. Pfizer Inc. has also developed Covid-19 vaccine administered throughout the nation.
Comparable Companies
The comparable companies to Johnson & Johnson is Pfizer and Moderna. The slide examine Pfizer Inc. that operates in a similar industry. Pfizer made global sales of $41.9 billion in 2020.
3
Moderna, Inc. is the second comparable company. It is an American biotechnology and pharmaceutical firm based in Massachusetts. The company is younger compared to J&J and Pfizer. It has 24 vaccine candidate entailing HIV, Covid-19, influenza, and Nipah virus. Moderna, Inc makes 65% of its returns from the Biomedical Advanced Research and Development Authority while 24% of the corporation’s returns were from other sections of federal government. The company made a gross loss of 5.75B.
Continuation
The presentation explain Moderna firm and its function. Moderna made a gross loss of 5.75B.
4
Benchmarking Analysis
The Benchmarking Analysis has page 1 and page 2. Page 1 analyzes parameters such as equity value, enterprise value, sales, gross profit, EBIT, EBITDA, and net income. Page 2 investigate the predicted Beta, ROIC, ROA, ROE, and the credit ratings of the firm.
5
Comparable Companies Analysis
The comparable companies analyzes the current share price, % of 52 wk. high, equity value, and enterprise value.
6
Mayes, T. R. (2020). Financial analysis with microsoft excel. Cengage Learning.
References
